• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug discovery

AI artificial intelligence drug development computational biology machine learning
Manufacturing

Excelsior nabs $95M to advance AI chemical synthesis aims

The funding haul includes a $70 million series A round that was co-led by Deerfield, Khosla Ventures and Sofinnova Partners, Excelsior said Wednesday.
Fraiser Kansteiner Dec 3, 2025 10:00am
Fierce 50 Breakthroughs Category Honorees

Fierce 50: Breakthroughs honorees

Oct 2, 2023 4:00am
Asia

Sun Pharma, XtalPi, Yuhan—Fierce Pharma Asia

Jun 2, 2023 1:21pm
AmgenFlag

Amgen showcases its scientists, AI advances in new podcast

Jul 7, 2022 7:45am
coronavirus vaccine

GSK, Sanofi vaccines safe from an mRNA downfall, analysts argue

Jun 16, 2021 11:15am
Novartis

Novartis enlists Microsoft to modernize drugs' path to market

Oct 3, 2019 7:55am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings